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Introduction
Lysophosphatidic acid (LPA, 1-acyl-2-lyso-sn-glycero-3-
phosphate) is an abundant serum mitogen that evokes growth-
factor-like responses in many cell types through activation of
G-protein-coupled receptors (GPCR) (Moolenaar, 1999). LPA
signaling affects a variety of cellular functions including:
growth stimulation (cell proliferation and cell survival) (Fang
et al., 2000; Goetzl et al., 2000; van Corven et al., 1992),
induction of cytoskeletal rearrangements via Rho GTPases
(Ridley and Hall, 1992), stimulation of serum-responsive genes
(Hill et al., 1995), neurite retraction (Jalink et al., 1994),
promotion of tumor cell migration/invasion (Stam et al., 1998)
and the secretion of peptide growth factors (Hu et al., 2001;
Pustilnik et al., 1999; Schwartz et al., 2001). Most of the effects
of LPA are mediated through the activation of three members
of the endothelial differentiation gene superfamily of receptors:
LPA1, LPA2 and LPA3 (Hla et al., 2001; Moolenaar, 1999).
Upon LPA binding, both LPA1 and LPA2 activate the Gi, Gq
and G12/13 families of heterotrimeric G proteins; LPA3 only
activates Gi and Gq (Ishii et al., 2000). In addition to these well-
characterized GPCRs, LPA also stimulates the orphan receptor,
GPR23/LPA4 (Noguchi et al., 2003) and the non-GPCR target,
peroxisome proliferator-activated receptor  (McIntyre et al.,
2003). Given the complexity of cellular responses to LPA
signaling and the potential role of LPA receptor subtypes in
various cancers (Mills and Moolenaar, 2003), it is important to
understand the mechanisms that regulate the activity of
individual LPA receptors.
Upon agonist stimulation, most GPCRs are rapidly
internalized into cells through a variety of different endocytic
pathways. This facilitates either receptor downregulation or
receptor resensitization (Marchese et al., 2003). Agonist
stimulation usually leads to the rapid phosphorylation of
serine/threonine residues located within cytoplasmically
exposed regions of GPCRs (Ferguson et al., 1995). This
subsequently induces the binding of -arrestin proteins, which
results in signal attenuation and often targets the GPCR to
clathrin-coated pits for endocytosis (Lefkowitz and Shenoy,
2005). Internalized GPCRs transit through the endosomal
system and are either sorted to lysosomes for degradation or
become dephosphorylated by membrane-associated
phosphatases and are recycled back to the plasma membrane
(Ferguson, 2001). In addition to clathrin-mediated endocytosis,
many GPCRs utilize a variety of clathrin-independent
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Lysophosphatidic acid (LPA) stimulates heterotrimeric G
protein signaling by activating three closely related
receptors, termed LPA1, LPA2 and LPA3. Here we show
that in addition to promoting LPA1 signaling, membrane
cholesterol is essential for the association of LPA1 with -
arrestin, which leads to signal attenuation and clathrin-
dependent endocytosis of LPA1. Reduction of clathrin
heavy chain expression, using small interfering RNAs,
inhibited LPA1 endocytosis. LPA1 endocytosis was also
inhibited in -arrestin 1 and 2-null mouse embryo
fibroblasts (-arrestin 1/2 KO MEFs), but was restored
upon re-expression of wild-type -arrestin 2. -arrestin
attenuates LPA signaling as LPA1-dependent
phosphoinositide hydrolysis was significantly elevated in -
arrestin 1/2 KO MEFs and was reduced to wild-type levels
upon re-expression of wild-type -arrestin. Interestingly,
extraction of membrane cholesterol with methyl--
cyclodextrin inhibited LPA1 signaling, -arrestin
membrane recruitment and LPA1 endocytosis. Cholesterol
repletion restored all of these functions. However, neither
the stimulation of phosphoinositide hydrolysis by the M1
acetylcholine receptor nor its endocytosis was affected by
cholesterol extraction. LPA treatment increased the
detergent resistance of LPA1 and this was inhibited by
cholesterol extraction, suggesting that LPA1 localizes to
detergent-resistant membranes upon ligand stimulation.
These data indicate that although LPA1 is internalized by
clathrin- and -arrestin dependent endocytosis, membrane
cholesterol is critical for LPA1 signaling, membrane
recruitment of -arrestins and LPA1 endocytosis.
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internalization mechanisms including cholesterol-dependent
pathways such as caveolae (Chini and Parenti, 2004). Also, -
arrestins are not universally required for GPCR endocytosis as
shown for the thrombin receptor, PAR1, whose association
with -arrestins is required for signal attenuation but not for
its endocytosis (Paing et al., 2002). Thus, the mechanisms that
regulate both signal attenuation and receptor endocytosis can
vary from one GPCR to another.
We have previously shown that LPA1 is probably
internalized by clathrin-dependent endocytosis as dominant-
negative mutants of dynamin 2 (K44A) and Rab 5 (S34N),
which regulate clathrin-dependent trafficking, strongly
inhibited LPA1 endocytosis (Murph et al., 2003). However, a
recent study showed that LPA stimulation of the
phosphoinositide 3-kinase (PI3-K)/Akt pathway was
dependent upon membrane cholesterol (Peres et al., 2003)
suggesting a positive role for cholesterol-rich plasma
membrane microdomains in LPA signaling. As cholesterol-
enriched microdomains, such as caveolae, can also mediate
receptor endocytosis, it is not clear what the relationship is
between LPA signaling from cholesterol-rich microdomains
and the endocytosis of LPA receptors. To address this question
and to gain a better understanding about the regulation of LPA
receptors, we investigated the role of membrane cholesterol, -





LPA) was purchased from Avanti Polar Lipids (Alabaster, AL).
Isoproterenol and cytochalasin D was obtained from Sigma Chemical
Co. (St Louis, MO) and carbachol from Fluka Chemika-Biochemika.
FLAG-tagged LPA1 receptors were detected with mouse anti-FLAG
antibodies (Sigma, St Louis, MO); HA-tagged 2AR and HA-tagged
M1 muscarinic acetylcholine receptor (mAChR) were detected with
mouse anti-HA antibodies (Covance, Berkeley, CA). Alexa 488-
labeled transferrin (Alexa 488-Tfn), Alexa 594- and Alexa 488-
conjugated goat anti-mouse were purchased from Molecular Probes
(Eugene, OR). Monoclonal antibodies to clathrin heavy chain and
monoclonal anti-actin antibodies were purchased from BD
Transduction labs (San Jose, CA) and Santa Cruz Biotechnology
(Santa Cruz, CA), respectively. Mouse anti-AP2 antibodies were
purchased from Affinity Bioreagents (Golden, CO). FITC-labeled
anti-CD59 was obtained from Chemicon (Temecula, CA). Methyl--
cyclodextrin and water-soluble cholesterol complexes were purchased
from Sigma. myo-[3H]inositol was purchased from American
Radiolabeled Chemicals (St Louis, MO).
Cell culture and DNA transfection
HeLa cells stably expressing the LPA1 receptor (termed LPA1/HeLa
cells), native HeLa cells, wild-type (WT) MEF and -arrestin 1/2 KO
MEF cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum, 100 IU/ml
penicillin, 100 g/ml streptomycin (Media Tech, Herndon, VA) and
1 mM sodium pyruvate (Biosource International, Camarillo, CA) at
37°C with 5% CO2. Cells were grown on glass coverslips (for
immunolocalization) and transfected in six-well dishes, or were grown
in 24-well dishes (for myo-[3H]inositol labeling) using Lipofectin or
Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to
manufacturer’s directions. Plasmids encoding HA-tagged 2AR, -
arrestin 1-GFP, -arrestin-2-GFP, HA-tagged M1 mAchR were
transiently transfected at 1.0 g/well (in six-well plates) and have
been previously described (Paing et al., 2002; Scott et al., 2002).
siRNA-mediated reduction of clathrin
siRNA oligonucleotides to clathrin were purchased from Dharmacon
(Lafayette, CO) and have been described previously (Motley et al.,
2003). LPA1/HeLa cells were transiently transfected with 300 pmol
(10 cm dish) or 100 pmol (24-well plate) of siRNA using
Lipofectamine 2000 (Invitrogen, Carlsbad, CA). The transfection
medium was replaced with complete medium (without
penicillin/streptomycin) 5 hours later and the cells were incubated for
16 hours. The cells were transfected a second time as above and the
medium was then replaced with serum-free medium (SFM) and
incubated for an additional 16 hours before experimentation.
Indirect immunofluorescence
Cells were treated as described in the figure legends, 24-48 hours after
transfection. Cells were then fixed in 2% formaldehyde in phosphate-
buffered saline (PBS) for 10 minutes and rinsed with 10% fetal bovine
serum (FBS) containing 0.02% azide in PBS (PBS-serum). Fixed cells
were incubated with primary antibodies diluted in PBS-serum
containing 0.2% saponin for 45 minutes and then washed (three times,
5 minutes each) with PBS-serum. The cells were then incubated in
fluorescently labeled secondary antibodies diluted in PBS-serum
containing 0.2% saponin for 45 minutes, washed three times with
PBS-serum, washed once with PBS and mounted on glass slides as
previously described (Murph et al., 2003).
For Alexa 594-Tfn and FITC-labeled anti-CD59 internalization,
LPA1/HeLa cells were briefly rinsed three times with 0.5% bovine
serum albumin (BSA) in SFM and incubated in the same medium for
30 minutes at 37°C. The cells were then incubated with Alexa 594-
conjugated human transferrin (50 g/ml) or FITC-conjugated anti-
CD59 (1 g/ml) for 30 minutes at 37°C in the presence or absence of
10 M LPA. Antibodies bound to the cell surface were removed by
rinsing the cells with 0.5% acetic acid, 0.5 M NaCl, pH 3.0 solution
(for Alexa 488-Tfn) or 100 mM glycine, 20 mM magnesium acetate,
50 mM KCl, pH 2.2 (for FITC anti-CD59) (Naslavsky et al., 2004).
Cells were rinsed in complete medium, fixed and processed for
fluorescence microscopy. For assessing uptake in the presence of
methyl--cyclodextrin (5 mM) or nystatin (50 g/ml), cells were pre-
treated with DMEM supplemented with 0.5% BSA, with or without
drugs, for 60 minutes prior to antibody and/or LPA addition. All
images were acquired using an Olympus BX40 epifluorescence
microscope equipped with a 60 Planapo lens and photomicrographs
were prepared using an Olympus MagnaFire SP digital camera
(Olympus America, Melville, NY). Images were processed with
Adobe Photoshop 6.0 software.
Quantification of LPA1 colocalization with internalized Alexa-
Tfn
Stably-transfected LPA1/HeLa cells or transiently-transfected HeLa
cells expressing M1 mAChRs were grown on glass coverslips and
treated with MCD and/or water-soluble cholesterol as described in
the figure legends. The cells were then incubated with 50 g/ml Alexa
594-Tfn for 30 minutes in the presence or absence of 10 M LPA or
1 mM carbachol, respectively. The cells were rinsed with a mild acid
wash as described above, fixed with 2% formaldehyde in PBS and
processed for immunofluorescence localization of LPA1 using M1
mouse anti-FLAG IgG or M1 mAChR using mouse anti-HA IgG
followed by Cy2 secondary antibodies. The extent of LPA1 or M1
colocalization with internalized Alexa 594-Tfn was determined by
quantifying the extent of pixel colocalization of GPCR staining with
Alexa 594-Tfn fluorescence using Metamorph Imaging software
(Universal Imaging, West Chester, PA) as described (Murph et al.,
2003; Volpicelli et al., 2001). The background was subtracted from
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unprocessed images and the percentage of GPCR pixels that
overlapped with Alexa-Tfn pixels was measured. The data is
presented as the mean±s.e.m. of measurements from 20 cells per
sample from a representative experiment that was performed three
independent times with similar results.
Immunoblotting 
Following 72 hours of siRNA treatment, cells were solubilized by
addition of lysis buffer (1% NP-40, 1% sodium deoxycholate, 0.1%
SDS, 0.15 M NaCl, 0.01 M sodium phosphate pH 7.2, 2 mM EDTA,
50 mM NaF, 0.2 M sodium orthovanadate, 0.02% azide, 100 g/ml
leupeptin and 0.1 mM PMSF) and incubated on ice for 60 minutes.
The samples (12 g protein per lane) were then separated by 10%
SDS-PAGE and transferred to nitrocellulose. Clathrin heavy chain
was detected using mouse anti-clathrin antibodies and actin was
detected using monoclonal anti-actin antibodies. The binding of
primary antibodies was detected by using an enhanced
chemifluorescence detection kit (Amersham Biosciences, Piscataway,
NJ).
Phosphoinositide hydrolysis
LPA1/HeLa cells or mouse embryo fibroblasts derived from wild-type
or -arrestin 1/2 null mice were plated at a density of 4.0104
cells/well into 24-well plates and transfected with plasmids encoding
wild-type LPA1 or M1 mAChRs alone or in combination with
plasmids encoding wild-type -arrestin 2 using Lipofectamine 2000.
Transient transfection of plasmids encoding M1 mAChRs was
performed by using Lipofectin reagent. At 24 hours post-transfection,
cells were labeled overnight with myo-[3H]inositol in inositol- and
serum-free medium, treated as described in the figure legends and then
processed for analysis of phosphoinositide hydrolysis by anion
exchange chromatography as described (Paing et al., 2002).
Triton X-100 extraction of cells
LPA1/HeLa cells were plated onto glass coverslips in 35 mm dishes
at a density of 0.2106 cells per plate. After allowing cells to attach
for 24 hours, the medium was changed to serum-free medium and the
cells were incubated overnight (~16 hours). The following day, the
cells were treated as described in the figure legends and subsequently
incubated with ice-cold 1% Triton X-100 in PBS on ice for 3 minutes
prior to fixation with ice-cold 2% formaldehyde in PBS. LPA1 or was
localized using indirect immunofluorescence microscopy. To monitor
the fate of surface LPA1, LPA1/HeLa cells were incubated on ice with
mouse anti-FLAG antibodies for 30 minutes after LPA treatment to
label only surface LPA1. These cells were then extracted with 1%
Triton X-100, fixed and processed for immunofluorescence
localization as described above. Relative receptor expression was
quantified by measuring receptor pixel intensity using MetaMorph
imaging software and was normalized to DNA content, labeled with
Hoescht dye.
Whole-cell ELISA quantification of surface LPA1
LPA1/HeLa cells were plated in 24-well dishes (Falcon) at a density
of 0.4105 cells per well and grown overnight. Cells were then
transiently transfected with no siRNA or with 100 pmol/well of
clathrin-specific siRNA (Motley et al., 2003) using Lipofectamine
2000 reagent according to the manufacturer’s instructions (Invitrogen,
Carlsbad, CA). After 24 hours, the cells were again transfected with
100 pmol/well of clathrin-specific siRNA or no siRNA. 24 hours later,
the cells were incubated in the presence or absence of 10 M LPA
for 45 minutes and fixed in 2% formaldehyde in phosphate-buffered
saline (PBS) for 10 minutes and rinsed with 10% fetal bovine serum
(FBS), containing 0.02% azide, in PBS (PBS-serum). Fixed cells were
incubated with mouse anti-M1 FLAG primary antibody diluted in
PBS-serum (250 l/well) for 1 hour and then washed (three times, 5
minutes each) with PBS-serum. The cells were then incubated with
horseradish peroxidase-conjugated goat anti-mouse IgG secondary
antibody (Pierce Biotechnology, Rockford, IL) diluted in PBS-serum
(250 l/well) for 1 hour, washed three times with PBS-serum and
washed three times with PBS. The cells were then incubated for 1
hour at 37°C with ABTS (2,2-Azinobis [3-ethylbenzothiazoline-6-
sulfonic acid]-diammonium salt) (Pierce Biotechnology). A 200 l
aliquot was then removed from each well, transferred to a 96-well
plate and the absorbance read at 405 nm (corrected for blank).
Internalization is expressed as the percent difference in surface LPA1
between unstimulated cells and agonist-stimulated cells. The data are
the mean±s.e.m. of six replicates/siRNA sample combined from two
independent experiments.
Cholesterol measurements
HeLa cells, stably expressing FLAG-tagged LPA1, were seeded in six-
well plates at a density of 0.5106 cells per well, allowed to attach
overnight and then incubated with serum-free DMEM for 24 hours
prior to treatment. The cells were treated for 60 minutes, as described
in the figure legend, rinsed twice with ice-cold PBS (pH 7.4) and then
solubilized in ice-cold PBS (pH 7.4) containing 1% Triton X-100 and
protease inhibitor cocktail (2 mM AEBSF, 1 mM EDTA, 130 M
bestatin, 14 M E-64, 1 M leupeptin and 0.3 M aprotinin). Total
cellular cholesterol was quantified using an Amplex Red Cholesterol
Assay Kit (Molecular Probes; Eugene, OR), as indicated by the
manufacturer. Briefly, cholesterol esters in the cell extracts are
hydrolyzed by cholesterol esterase into cholesterol, which is then
oxidized by cholesterol oxidase to yield H2O2, which is detected using
10-acetyl-3,7-dihydroxyphenoxazine (Amplex Red). In the presence
of horseradish peroxidase (HRP), Amplex Red reacts with H2O2 to
produce fluorescent resorufin. Fluorescence was measured with a
fluorescence microplate reader using excitation at 560 nm and
fluorescence detection at 590 nm and total cholesterol was calculated
from a standard curve using purified cholesterol. Cellular cholesterol
was normalized to total protein concentration, which was quantified
by BCA Protein Assay (Pierce Biotechnology).
Statistical analysis
The data is expressed as the mean±s.e.m. from the indicated number
of independent experiments performed in triplicate. Differences were
analyzed by two-factor ANOVA followed by a Tukey’s statistical
significance test.
Results
LPA1 is internalized by clathrin-mediated endocytosis
Our previous work suggested that LPA1 was internalized by
clathrin-dependent endocytosis based on the inhibitory effects
of mutant dynamin 2 K44A and Rab 5 S34N (Murph et al.,
2003). However dynamin K44A can also inhibit endocytosis
from cholesterol-rich caveolae (Damke et al., 1994; Henley et
al., 1998; Murph et al., 2003). To directly test whether LPA1
used a clathrin-dependent pathway, we determined the effects
of reducing the cellular abundance of the clathrin heavy chain,
using small interfering RNAs (siRNAs), on the endocytosis of
LPA1. Fig. 1A shows the distribution of FLAG-tagged LPA1 in
stably transfected HeLa cells (LPA1/HeLa cells). In untreated
cells, LPA1 is localized predominantly at the plasma membrane
and to a lesser extent, at the Golgi complex, which probably
represents newly synthesized LPA1 en route to the plasma
membrane. Treatment with 10 M LPA results in a












we have previously shown to colocalize with transferrin-
receptor-positive endosomes (Murph et al., 2003).
To investigate the role of clathrin in LPA1 endocytosis, we
adapted a double-transfection procedure that was previously
described (Motley et al., 2003) to knock down clathrin heavy
chain amounts in HeLa cells to near undetectable levels. Using
this procedure, we observed a 73% reduction in the abundance
of clathrin relative to mock-transfected siControl cells (Fig.
1B) in LPA1/HeLa cells. Treatment of cells with clathrin
siRNA did not alter the abundance of actin. Endocytosis of
LPA1 was quantified by using a whole-cell ELISA, which
measures the agonist-induced loss of cell surface LPA1 (Kim
and Benovic, 2002; Paing et al., 2002). In siControl cells, 10
M LPA induced LPA1 internalization (~30%) and this was
strongly inhibited in siClathrin cells (~2%) (Fig. 1C). In
siClathrin cells, both the agonist-stimulated internalization of
2-adrenergic receptors (2ARs) (data not shown), which are
known to use clathrin-dependent mechanisms (von Zastrow
and Kobilka, 1992) and the constitutive endocytosis of Alexa
transferrin was strongly inhibited (Fig. 1D).
As a negative control, we examined the effects of clathrin
knockdown on the endocytosis of anti-CD59 antibodies bound
to endogenous CD59, which is internalized via cholesterol-
rich, detergent-resistant membranes and then merges with a
clathrin-independent trafficking pathway that is regulated by
the Arf6 GTPase as shown by Naslavsky et al. (Naslavsky et
al., 2004). LPA1/HeLa cells were transfected either with or
without clathrin siRNAs and then incubated with FITC-labeled
mouse anti-CD59 antibodies along with Alexa 594-Tfn for 30
minutes. The cells were acid-stripped to remove surface-bound
anti-CD59 antibodies and Alexa 594-Tfn. In cells transfected
with clathrin siRNAs, FITC-labeled anti-CD59 antibodies
localized to pleomorphic tubulovesicular structures (Fig. 1D,
Anti-CD59) similar to those described (Naslavsky et al., 2004).
As expected, these same siRNA-treated cells did not internalize
Alexa 594-Tfn (Fig. 1D, Alexa 594-Tfn). Taken together, these
results indicate that LPA1 is internalized by clathrin-mediated
endocytosis.
-arrestins are critical for LPA1 signal attenuation and
receptor endocytosis
Clathrin-mediated endocytosis of many GPCRs is also
dependent upon their association with the multi-functional -
arrestins (Ferguson et al., 1996; Marchese et al., 2003). -
arrestin binding is initiated through the agonist-induced
phosphorylation of cytoplasmic serine/threonine residues in
the GPCR by G protein receptor kinases (GRKs) such as
GRK2 (Pitcher et al., 1998). -arrestin binding promotes both
receptor desensitization, by preventing receptor-G protein
coupling and clathrin-dependent endocytosis of the receptor.
To determine whether -arrestins are required for LPA1
endocytosis, we compared agonist-stimulated internalization
of LPA1 and 2AR in mouse embryo fibroblasts (MEFs)
derived from either wild-type or -arrestin 1 and 2 null mice
(Kohout et al., 2001) (Fig. 2). Wild-type MEFs were transiently
transfected with plasmids encoding either LPA1 or 2ARs and
then incubated in the presence or absence of agonist. In the
absence of agonist treatment, both receptors were primarily
localized to the plasma membrane in a diffuse pattern (Fig. 2A,
untreated). Upon agonist treatment for 30 minutes, both LPA1
and 2ARs redistributed to small punctate endosomal
Journal of Cell Science 118 (22)
Fig. 1. siRNA-mediated reduction of clathrin
inhibits agonist-induced endocytosis of LPA1.
(A) Stably-transfected LPA1/HeLa cells were
incubated in the presence or absence of 10 M
LPA for 30 minutes, fixed and processed for
immunofluorescence detection of FLAG-tagged
LPA1 with M1 mouse anti-FLAG antibodies and
fluorescently-labeled secondary antibodies.
(B) Cell lysates were prepared from stably-
transfected LPA1/HeLa cells, which were either
mock transfected (siControl) or transfected with
clathrin siRNA (siClathrin) for 48 hours,
separated by SDS-PAGE and immunoblotted for
clathrin heavy chain (CHC) or actin. (C) Stably-
transfected LPA1/HeLa cells grown in 24-well
plates were either mock transfected (siControl) or
transfected with clathrin siRNA (siClathrin) for
48 hours prior to treatment with or without 10
M LPA for 45 minutes. The cells were fixed and
processed for whole-cell ELISA to quantify
surface LPA1 receptors as described in Materials
and Methods. LPA1 internalization is expressed as
the percentage difference in surface LPA1
between unstimulated cells and agonist-stimulated
cells. The data are the mean±s.e.m. of six
replicates/siRNA sample combined from two
independent experiments. **P<0.01 compared to
levels in the siControl. (D) Stably transfected LPA1/HeLa cells were treated with clathrin siRNA for 48 hours prior to incubation with FITC-labeled
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structures dispersed throughout the cell. The labeling of these
structures was not observed in non-permeabilized cells, thus
indicating that they were internal endosomal structures (Fig.
1A, non-permeabilized). In contrast to wild-type MEFs,
agonist treatment of -arrestin 1/2 KO MEFs expressing either
LPA1 or 2ARs did not lead to their endocytosis (Fig. 2B,
+agonist). Expression of wild-type -arrestin-2-GFP in the
knockout cells restored agonist-induced endocytosis of both
LPA1 (Fig. 3A, 30 minutes) and 2ARs (data not shown), thus
indicating that -arrestins were required for the endocytosis of
LPA1 as well as 2ARs.
Previous studies have shown that agonist stimulation of
different GPCRs leads to the translocation of cytosolic -
arrestin proteins to the plasma membrane (Barak et al., 1997).
For some GPCRs such as 2ARs, this association with -
arrestins is transient and is not observed following receptor
endocytosis, whereas other GPCRs, such as angiotensin AT1a
receptors and vasopressin receptors, maintain a stable
association with -arrestins even on endosomes after
endocytosis (Oakley et al., 1999). To determine whether LPA1
formed a transient or stable association with -arrestins, we
examined the distribution of LPA1 and -arrestin-2-GFP after
0, 2 and 30 minutes of LPA treatment (10 M) (Fig. 3A). In
untreated cells, LPA1 localized to the plasma membrane and
-arrestin-2-GFP localized in a diffuse cytoplasmic pattern
(Fig. 3A, Untreated). After 2 minutes of LPA treatment, LPA1
localized to small punctate structures, which partially
colocalized with -arrestin-2-GFP (Fig. 3A, inset, arrows).
However, many punctate structures contained LPA1 but did not
contain -arrestin-2-GFP, particularly in the larger and more
pleotropic structures. Following 30 minutes of LPA treatment,
LPA1 localized to heterogeneously sized endosomal structures,
but -arrestin-2-GFP returned to the diffuse cytoplasmic
pattern observed in untreated cells (Fig. 3A, 30 minutes). This
suggested that -arrestins dissociate from LPA1 receptors at or
near the cell surface and do not form a stable association with
-arrestin proteins, as defined by Oakley et al. (Oakley et al.,
1997). Taken together, these data indicate that -arrestins are
critical for the endocytosis of LPA1 and that LPA1 only
transiently associates with -arrestins at the cell surface.
As mentioned above, -arrestin binding to activated GPCRs
leads to signal attenuation (Lefkowitz and Whalen, 2004). We
next investigated whether -arrestins were important for the
desensitization of LPA1. We examined the ability of LPA1
receptors, which activate Gi, Gq and G12/13 signaling pathways
(Fukushima et al., 1998), to promote phosphoinositide (PI)
hydrolysis, via Gq stimulation of phospholipase C, in the wild
type and -arrestin 1/2 KO MEFs (Fig. 3B). LPA1-transfected
wild type and -arrestin 1/2 KO MEFs were labeled with
[3H]inositol and the accumulation of inositol phosphates was
determined in untreated cells and cells treated with 10 M LPA
for 60 minutes at 37°C. LPA treatment increased the
accumulation of [3H]inositol phosphates in wild-type MEFs by
~2.5-fold. However, stimulation of LPA1-transfected -arrestin
1/2 KO MEFs led to a 4.3-fold increase in inositol phosphate
accumulation, suggesting that -arrestins are important for
attenuation of LPA signaling. To further test this, we
determined the effects of re-expression of wild-type -arrestin
2 on inositol phosphate accumulation in LPA1-transfected -
arrestin 1/2 KO MEFs (Fig. 3B). Co-transfection of wild-type
-arrestin 2 and LPA1 in the -arrestin 1/2 KO MEFs reduced
the magnitude of LPA-induced inositol phosphate
Fig. 2. Agonist-induced endocytosis of LPA1 is inhibited in
-arrestin 1/2 double knockout mouse embryo fibroblasts.
(A) Wild-type MEFs were transiently transfected with
plasmids encoding either FLAG-tagged LPA1 or HA-tagged
2AR and then incubated in the presence or absence of
agonist (10 M LPA or 20 M isoproterenol, respectively)
for 30 minutes prior to indirect immunofluorescence
localization of the receptor proteins either in the presence or
absence of detergent permeabilization. (B) -arrestin 1/2
double knockout MEFs were transiently transfected with
plasmids encoding either FLAG-tagged LPA1 or HA-tagged
2ARs and incubated in the presence or absence of agonist,
as above, prior to indirect immunofluorescence localization












accumulation to 3.1-fold, which was similar to that observed
in LPA1-transfected WT MEFs (2.5-fold). Taken together,
these observations strongly support the notion that -arrestin
association with LPA1 receptors is important for signal
attenuation and for clathrin-mediated receptor internalization.
Membrane cholesterol is required for LPA1 signaling and
receptor endocytosis
Having established that the agonist-induced endocytosis of
LPA1 was mediated by a -arrestin- and clathrin-dependent
pathway, we next investigated the role of membrane cholesterol
in LPA1 signaling and trafficking. As mentioned, membrane
cholesterol has been shown to be important for LPA
stimulation of PI3-kinase/Akt signaling (Peres et al., 2003). To
address this question, we first examined the effects of
cholesterol extraction with methyl--cyclodextrin (MCD)
and the effects of cholesterol disruption with the cholesterol-
binding drug, nystatin, on LPA stimulation of phosphoinositide
hydrolysis, which is stimulated by Gq signaling. As a first step,
we measured the effects of these cholesterol-perturbing drugs
and the effects of water-soluble cholesterol:MCD complexes
on the cellular abundance of cholesterol in LPA1/HeLa cells by
using a quantitative cholesterol measurement assay (see
Materials and Methods) (Table 1). Control LPA1/HeLa cells
contained 17.10±0.13 g cholesterol/mg protein and treatment
with 5 mM MCD for 1 hour reduced cellular cholesterol by
62% to 6.52±0.05 g cholesterol/mg protein. Addition of 10
mM cholesterol, as a water-soluble MCD complex, for 1 hour
after MCD extraction, increased cellular cholesterol levels to
approximately twice that observed in control cells (34.2±0.78
g cholesterol/mg protein). In contrast, treatment of
LPA1/HeLa cells with 50 g/ml nystatin for 1 hour slightly
elevated the amount of cellular cholesterol (20.8±1.5 g
cholesterol/mg protein) and addition of water-soluble
cholesterol to nystatin-treated cells increased cellular
cholesterol amounts by approximately 2.5-fold relative to
control LPA1/HeLa cells (42.9±1.3 g cholesterol/mg protein).
This is consistent with the notion that nystatin merely binds
sterols but does not extract them from cells.
We next examined the effects of these cholesterol-perturbing
drugs on LPA1 stimulation of phosphoinositide hydrolysis,
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Fig. 3. Re-expression of wild-type -arrestin 2 GFP in -arrestin
knockout MEFs restores LPA1 signal attenuation and receptor
endocytosis. (A) -arrestin 1/2 double knockout MEFs were
transiently transfected with plasmids encoding LPA1 and wild-type
-arrestin-2-GFP. Cells were then incubated with 10 M LPA for 0,
2, or 30 minutes prior to fixation and indirect immunofluorescence.
The inset shows a magnified image of the boxed region and the
arrows indicate punctate structures that co-label for both LPA1 and
-arrestin-2-GFP. Note that the recruitment of -arrestin2-GFP to
these punctate structures is transient, observable after 2 minutes of
LPA treatment but not after 30 minutes of LPA treatment. (B) MEFs
derived from wild type (WT) or -arrestin 1/2 null (Arr 1/2KO)
mice were transfected with plasmid encoding wild-type LPA1
receptors; -arrestin 1/2 null MEFs were also co-transfected with
plasmids encoding LPA1 and wild-type -arrestin 2 (Arr 1/2KO +
LPA1 + WT Arr2). Cells were then labeled with [3H]myo-inositol
overnight in serum-free medium and incubated for 1 hour in the
absence (Untreated) or presence of 10 M LPA prior to analysis of
phosphoinositide hydrolysis, as described in Materials and Methods.
The radioactivity recovered in the different samples was normalized
to total cellular protein and the data are presented as the mean±s.e.m.
of triplicate measurements from a representative experiment that was
repeated three times. **P<0.01, comparison of LPA-stimulated
phosphoinositide hydrolysis in -arrestin 1/2 KO MEFs to that
observed in WT MEFs. Bar, 10 m.





5 mM MCD 6.5±0.05
5 mM MCD + 10 mM cholesterol/MCD 34.2±0.78
50 g/ml Nystatin 20.8±1.5
50 g/ml Nystatin + 10 mM cholesterol/MCD 42.9±1.3
*Stably transfected LPA1/HeLa cells were left untreated (Control) or were
incubated with 5 mM MCD for 1 hour, 50 g/ml nystatin for 1 hour, 5 mM
MCD for 1 hour followed by 10 mM cholesterol/MCD for 1 hour or 50
g/ml nystatin for 1 hour followed by 10 mM cholesterol/MCD for 1 hour.
Cells were then solubilized and total cellular cholesterol content was
quantified as described in the Materials and Methods. The amount of cellular
cholesterol was normalized to total cellular protein and is presented as the
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which is promoted by Gq stimulation of phospholipase C. LPA
stimulation of native HeLa cells (Fig. 4A, HeLa) resulted in a
small 1.9-fold increase in accumulation of [3H]inositol
phosphates, whereas stimulation of LPA1/HeLa cells resulted
in a large increase in PI hydrolysis (~14-fold) (Fig. 4A, lane
1). Treatment of LPA1/HeLa cells with 5 mM MCD reduced
LPA stimulated PI hydrolysis to 3.9-fold (72% inhibition) (Fig.
4A, lane 2). Treatment of LPA1/HeLa cells with 50 g/ml
nystatin did not significantly affect agonist-dependent PI
hydrolysis (Fig. 4A, lane 4). Addition of water-soluble
cholesterol:MCD complexes, which contained 10 mM
cholesterol, to MCD-treated or nystatin-treated cells greatly
increased the extent of basal accumulation of labeled inositol
phosphates (Fig. 4A, lanes 3 and 5). Addition of water-soluble
cholesterol led to a greater increase in the basal level of inositol
phosphate accumulation as compared to that observed in LPA-
stimulated samples, which consequently decreased the fold
induction of PI hydrolysis by LPA. This could be due to
enhanced Gq signaling that is independent of LPA1 receptors.
These results suggested that the presence of membrane
cholesterol was important for LPA1 stimulation of PI
hydrolysis.
As a control, we examined the effects of MCD on the
stimulation of PI hydrolysis by an unrelated Gq-coupled
receptor, the M1 muscarinic acetylcholine receptor (M1
mAChR). For these experiments, HeLa cells were transiently
transfected with plasmids encoding either wild-type LPA1 or
M1 mAChRs. Whereas 5 mM MCD inhibited LPA1-mediated
PI hydrolysis (Fig. 4B, compare lanes 3 and 4) as expected, it
did not significantly reduce the extent of PI hydrolysis in
response to agonist stimulation (1 mM carbachol) of M1
mAChR-expressing cells (Fig. 4B, compare lanes 5 and 6).
Immunofluorescence microscopy indicated that the
transfection efficiencies of the LPA1 and M1 mAChR plasmids
were comparable and were approximately 40% (data not
shown). These results indicated that the reduction of LPA1-
mediated PI hydrolysis by MCD was not due to inhibition of
either Gq or phospholipase C activities, but rather was due to
a specific inhibition of LPA1 function. Taken together, these
results suggest that the presence of plasma membrane
cholesterol is critical for LPA1-dependent signaling to
phospholipase C (Fig. 4).
Next, we investigated whether membrane cholesterol was
also important for LPA1 endocytosis. We compared the effects
of MCD on the agonist-induced endocytosis of LPA1 and M1
mAChRs, which are also internalized by clathrin- and -
arrestin-dependent mechanisms (Vogler et al., 1999). Stably-
transfected LPA1/HeLa cells or transiently-transfected HeLa
cells expressing M1 mAChRs were pre-incubated in the
presence or absence of 5 mM MCD for 1 hour. These cells
were then incubated with the respective agonists and Alexa
594-Tfn for 30 minutes. In untreated cells, LPA1 and M1
mAChRs localized to the plasma membrane, whereas Alexa
594-Tfn labeled pleomorphic endosomal structures (Fig. 5A,
untreated). Agonist stimulation induced the endocytosis of
Fig. 4. Stimulation of phosphoinositide hydrolysis by LPA1 receptors
is inhibited by cholesterol extraction with methyl--cyclodextrin.
(A) Either native HeLa cells or stably transfected LPA1/HeLa cells
were labeled overnight with [3H] myo-inositol and then either left
untreated (HeLa and lane 1) or pre-incubated with 5 mM MCD for
1 hour (lane 2), 50 g/ml nystatin for 1 hour (lane 4), 5 mM MCD
for 1 hour followed by 10 mM cholesterol/MCD complexes for 60
minutes (lane 3), or 50 g/ml nystatin for 1 hour followed by 10 mM
cholesterol/MCD complexes for 60 minutes (lane 5) prior to an
additional 1 hour treatment with 10 M LPA. Cells were then
solubilized and the total accumulation of labeled inositol phosphates
was determined. The radioactivity recovered in the different samples
was normalized to total cellular protein and the data are presented as
the mean±s.e.m. of triplicate measurements from a representative
experiment that was repeated four times. **a, P<0.01, comparison of
LPA-stimulated phosphoinositide hydrolysis in MCD-treated
LPA1/HeLa cells to that observed in non-MCD-treated LPA1/HeLa
cells. **b, P<0.01, comparing phosphoinositide hydrolysis in
MCD-treated or nystatin-treated LPA1/HeLa cells that were
incubated with water-soluble cholesterol to that observed in
unstimulated LPA1/HeLa cells. (B) HeLa cells were transiently
transfected with plasmids encoding either vector alone (lanes 1 and
2), LPA1 (lanes 3 and 4), or M1 mAChRs (lanes 5 and 6). The cells
were incubated in the absence (–) or presence (+) of 5 mM MCD
for 1 hour prior to a subsequent 1 hour incubation with agonist (10
M LPA or 1 mM carbachol). After solubilization, the radioactively-
labeled inositol phosphates were isolated as described. The
radioactivity recovered in the different samples was normalized to
total cellular protein and the data are presented as the mean±s.e.m. of
triplicate measurements from a representative experiment that was
repeated three times. **P<0.01, comparison of LPA-stimulated
phosphoinositide hydrolysis in MCD-treated LPA1-transfected












both receptors into endosomal structures that colocalized with
internalized Alexa 594-Tfn (Fig. 5A, +agonist). To quantify
GPCR endocytosis, we measured the extent of GPCR (either
LPA1 or M1) colocalization with the internalized Alexa 594-
Tfn using Metamorph image analysis (Murph et al., 2003;
Volpicelli et al., 2001). In control cells, treatment with 10 M
LPA increased LPA1 and Alexa 594-Tfn colocalization by 3.3-
fold relative to untreated cells (Fig. 5B, Control). Pre-
incubation with 5 mM MCD reduced this agonist-induced
colocalization by more than 50% (Fig. 5B, compare black bars
in control cells to cells treated with 5 mM MCD). Addition
of 10 mM water-soluble cholesterol restored LPA1 and Alexa
594-Tfn colocalization to near control levels (Fig. 5B, MCD
+ cholesterol). In contrast to LPA1, agonist treatment (1 mM
carbachol, 30 minutes) stimulated a twofold increase in M1
mAChR colocalization with Alexa 594-Tfn, which was not
inhibited by MCD (Fig. 5C). These data suggested that
plasma membrane cholesterol is important for both LPA1
endocytosis and LPA1 signaling.
LPA1 localizes to detergent-resistant membrane
microdomains upon agonist stimulation
Although the data above indicates that membrane cholesterol is
essential for LPA1 endocytosis, the data in Fig. 1-3 indicate that
LPA1 is internalized by clathrin- and -arrestin-dependent
mechanisms, which are distinct from cholesterol-dependent
endocytic pathways (Nichols, 2003). To further investigate this
apparent difference, we examined whether LPA1 localized to
detergent-resistant membrane domains, which are enriched in
both cholesterol and glycosphingolipids (Razani et al., 2002).
We examined the effects of LPA stimulation on the resistance
of LPA1 to extraction with Triton X-100. LPA1/HeLa cells were
incubated with 10 M LPA for different times before extraction
with ice-cold 1% Triton X-100 and indirect
immunofluorescence (Fig. 6A). LPA1 staining in unstimulated
cells was greatly reduced following Triton X-100 extraction
(Fig. 6A, 0 minute). In contrast, the cell-associated LPA1
staining, which remained after detergent extraction, was
increased with time of agonist stimulation (Fig. 6A). We
quantified the detergent-resistant LPA1 staining associated with
the cells by measuring the pixel intensity of LPA1-specific
fluorescence using MetaMorph image analysis (see materials
and methods) and normalizing this value to DNA content as
assessed by Hoescht dye labeling (Fig. 6B). This analysis
showed that detergent extraction of unstimulated cells reduced
the level of cell-associated LPA1 staining to 5% of that observed
in untreated and non-extracted cells. Cell-associated LPA1
staining progressively increased with time of LPA treatment
such that after 30 minutes of LPA stimulation approximately
38% of LPA1 immunoreactive staining remained after detergent
extraction, relative to control cells (Fig. 6B, solid circles).
Extraction of membrane cholesterol with 5 mM MCD prior to
LPA stimulation blocked the LPA-induced increase in detergent
resistance of LPA1 (Fig. 6B, open triangles). As detergent
resistance of proteins can also be increased by their association
with the actin cytoskeleton, we examined the effects of
inhibiting actin polymerization with cytochalasin D (5 M) on
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Fig. 5. Cholesterol extraction inhibits the agonist-
induced endocytosis of LPA1 but not M1 mAChRs.
(A) HeLa cells were transiently transfected with
plasmids encoding either LPA1 or M1 mAChRs
and were incubated in the absence (Untreated) or
presence of agonist (10 M LPA or 1 mM
carbachol, respectively) and 50 g/ml Alexa 594-
Tfn for 30 minutes and then processed for indirect
immunofluorescence localization of the transfected
receptors. Bar, 10 m. (B and C) HeLa cells were
transfected as described above and were pre-
incubated for 1 hour in the absence (Control) or
presence of 5 mM MCD or MCD and 10 mM
cholesterol/MCD complexes prior to a
subsequent incubation in the presence or absence
of 10 M LPA and 50 g/ml Alexa 594-Tfn. The
cells were fixed and processed for
immunofluorescence localization of the transfected
receptors. The extent of colocalization between
LPA1 (B) or M1 mAChRs (C) and the internalized
Alexa 594-Tfn was quantified using Metamorph
image analysis as described in Materials and
Methods. The data are expressed as the
mean±s.e.m. of 20 cells/condition from a
representative experiment that was performed three
times with similar results. **P<0.01 compared
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the detergent resistance of LPA1 (Fig. 6B, open squares). We
observed no noticeable difference between the detergent
resistance of LPA1 in cells pre-treated with cytochalasin D and
untreated cells, after brief exposure to LPA (i.e. 0 to 8 minutes).
A slight delay in the rate of increase of LPA1 detergent
resistance was observed between 10 and 20 minutes of LPA
treatment in cells that were pre-treated with cytochalasin D, but
the extent of detergent resistance was the same in both untreated
and cytochalasin D-treated cells after 30 minutes of LPA
stimulation. These data indicate that LPA treatment promotes
the association of LPA1 with detergent resistant membranes and
that this process is inhibited by cholesterol extraction.
Given that LPA treatment for 30 minutes promotes the
endocytosis of LPA1 into transferrin receptor+ endosomes, it is
likely that some of the detergent resistant LPA1 receptors
observed after longer LPA treatment reside in endosomes.
Fig. 6. LPA1 receptors localize to detergent-resistant cellular domains upon agonist stimulation. (A) LPA1/HeLa cells were incubated with 10
M LPA for different times and subsequently treated with 1% cold Triton X-100 on ice for 3 minutes, fixed and processed for indirect
immunofluorescence localization of LPA1. (B) Quantitative analysis of receptor expression after detergent extraction was performed by
MetaMorph image analysis as described in Materials and Methods. Cells were either untreated, treated with 5 M cytochalasin D (Cyto. D) for
30 minutes, or treated with 5 mM MCD for 1 hour, prior to incubation with 10 M LPA for the indicated times. The LPA1 labeling in
detergent-extracted cells was normalized to the amount of LPA1 labeling observed in non-agonist-treated cells, which had not been subjected to
detergent extraction. The data are presented as the mean±s.e.m. of five to six cells per time point and are from a representative experiment that
was repeated twice with similar results. (C) LPA1/HeLa cells were incubated with 10 M LPA for different times and incubated with mouse
anti-FLAG antibody on ice for 30 minutes prior to extraction with ice-cold 1% Triton X-100, to label surface LPA1 receptors. Cells were then
processed for indirect immunofluorescence localization of surface LPA1. (D) Quantitative analysis of surface LPA1 receptor expression after
detergent extraction was performed by MetaMorph image analysis as described in Materials and Methods. The LPA1 labeling in detergent-
extracted cells was normalized to the amount of LPA1 labeling observed in non-agonist treated cells, which had not been subjected to detergent
extraction. The data are presented as the mean±s.e.m. of five to six cells per time point and are from a representative experiment that was
repeated twice with similar results. **P<0.01, comparison of the amount of detergent-resistant surface LPA1 staining after the indicated time of












Studies have shown that transferrin receptor+ endosomes are
enriched in cholesterol (Hao et al., 2002). To investigate the
effects of agonist stimulation on the detergent resistance of
surface LPA1 receptors, we labeled surface LPA1 with mouse
anti-FLAG antibodies on ice prior to detergent extraction (Fig.
6C,D). The LPA1 expressed in LPA1/HeLa cells contains an N-
terminal FLAG epitope tag that is accessible to the
extracellular medium. In the absence of detergent, mouse anti-
FLAG antibodies labeled only the cell surface in control cells
(Fig. 6C, Control). Triton X-100 extraction removed most of
the surface-bound antibody (only 15% of control, un-extracted
cells remained) (Fig. 6C,D, 0 minute). The detergent resistance
of surface LPA1 increased with time of agonist treatment up to
45% of control levels after 6 minutes and then declined after
15 minutes and 30 minutes of LPA treatment (Fig. 6C,D).
These results suggest that the LPA1 receptor associates with
detergent-resistant membranes following agonist stimulation,
both at the cell surface and following endocytosis in
cholesterol-rich endosomes.
Membrane cholesterol is required for the plasma
membrane recruitment of cytosolic -arrestins by
activated LPA1
As -arrestins are required for the clathrin-mediated
endocytosis of LPA1, we examined whether membrane
cholesterol was important for the association of -arrestins
with LPA1 or with 2AR, as a control. Preliminary experiments
showed that, in HeLa cells that were transiently transfected
with plasmid encoding either LPA1 or 2ARs along with -
arrestin -2-GFP, both LPA1 and 2ARs transiently recruited
cytosolic -arrestin-2-GFP to punctate plasma membrane
structures after 2 minutes of agonist stimulation (Fig. 8A,B,
Control). Double-labeling experiments showed that -arrestin-
2-GFP extensively colocalized with the plasma membrane
clathrin adaptor, AP2 (Fig. 7), suggesting that brief LPA
stimulation led to the recruitment of -arrestin-2-GFP to cell
surface clathrin-coated pits. After 30 minutes of agonist
stimulation, both LPA1 and 2ARs localized to endosomal
structures, but -arrestin 2 GFP returned to a cytosolic
distribution (data not shown). This is consistent with published
reports showing that 2ARs transiently associate with -
arrestins (Oakley et al., 1999).
We next examined the effects of cholesterol extraction on
the surface recruitment of -arrestin-2-GFP by LPA1 and 2AR
after 2 minutes of agonist stimulation (Fig. 8). -arrestin-2-
GFP localized in a diffuse cytoplasmic pattern in unstimulated
cells and both LPA1 and 2AR were localized to the plasma
membrane (data not shown). After 2 minutes of LPA treatment,
-arrestin-2-GFP colocalized with LPA1 in punctate spots at
the cell surface (Fig. 8A, Control, left panels), which also
colocalized with AP2 (see Fig. 7). Similarly, after 2 minutes of
isoproterenol treatment of 2AR-expressing cells, -arrestin-
2-GFP localized to punctate spots at the cell surface (Fig. 8B,
Control, right panels). Pre-incubation with 5 mM MCD for
60 minutes completely inhibited the recruitment of -arrestin-
2-GFP to the cell surface by LPA1 and -arrestin-2-GFP
remained in a diffuse cytosolic distribution (Fig. 8A, MCD,
see inset). Addition of 10 mM water-soluble cholesterol
restored the ability of LPA1 to recruit -arrestin-2-GFP to the
cell surface in MCD-treated cells (Fig. 8A, MCD-
cholesterol). In contrast, incubation with MCD did not inhibit
-arrestin-2-GFP recruitment to punctate surface spots by
2ARs (Fig. 8B, MCD, see inset). Addition of water-soluble
cholesterol did not alter the surface recruitment of -arrestin
2-GFP by 2ARs (Fig. 8B, MCD-cholesterol).
To quantify these effects, we determined the percentage of
cells that showed -arrestin recruitment to the plasma
membrane after 2 minutes of agonist stimulation of either LPA1
or 2AR (Fig. 8C). In control cells and in cholesterol repleted
cells (i.e. MCD-cholesterol), -arrestin-2-GFP was recruited
to the cell surface in ~80% of cells expressing either LPA1 or
2AR. Only 4% of LPA1-expressing cells showed surface
recruitment of -arrestin-2-GFP in MCD-treated cells. In
contrast, approximately 50% of 2AR-expressing cells
exhibited surface recruitment of -arrestin-2-GFP. Taken
together, these results indicate that LPA1 is much more
dependent upon plasma membrane cholesterol for the
recruitment of -arrestin than 2ARs. This also provides a
possible link between membrane cholesterol and clathrin-
dependent endocytosis of LPA1 as -arrestin is critical for
endocytosis of LPA1.
Discussion
All members of the GPCR superfamily share the ability to
rapidly respond to agonist stimulation and then to undergo
desensitization (Lefkowitz and Shenoy, 2005). Many of these
GPCRs are also rapidly internalized into cells via one of several
distinct endocytic pathways. However, the mechanisms that
regulate GPCR desensitization and determine the specific
endocytic pathway used for internalization vary from receptor
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Fig. 7. LPA stimulation leads to the colocalization of -arrestin-2-
GFP with clathrin AP2 adaptors. LPA1/HeLa cells were transiently-
transfected with plasmids encoding -arrestin-2-GFP and incubated
with 10 M LPA for either 0 minute or 2 minutes prior to fixation.
Endogenous clathrin AP2 was localized in permeabilized cells using
mouse anti-AP2 antibodies. The inset shows a high magnification
image of the boxed region and the arrows indicate structures where
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to receptor. In this study, we found that LPA1 receptors are
internalized by a clathrin- and -arrestin-dependent pathway,
but that they also require plasma membrane cholesterol for
receptor signaling and for their subsequent clathrin-dependent
endocytosis. Our results indicate that the key requirement of
membrane cholesterol for LPA1 endocytosis is for the
association of LPA1 with -arrestin, which promotes both signal
attenuation and clathrin-dependent endocytosis of the receptor.
Caveolae and other detergent-resistant membrane domains
are cholesterol- and glycosphinoglipid-rich, are sites of active
signal transduction and have been implicated in the activation
of heterotrimeric G proteins, Ras signaling and eNOS signaling
(Razani et al., 2002). Several lines of evidence suggest that
LPA1Rs associate with cholesterol-rich, detergent-resistant
membranes and that this is important for LPA1-dependent
signaling. First, cholesterol extraction with MCD strongly
inhibited LPA1 induction of phosphoinositide hydrolysis, via
Gq-mediated stimulation of phospholipase C (Fig. 4). Gq has
been shown to be enriched in caveolae (Huang et al., 1997; Oh
and Schnitzer, 2001), which supports the notion that LPA1
Fig. 8. MCD extraction prevents recruitment of -arrestin-2-GFP to the plasma membrane by LPA1 but not by 2AR. (A,B) HeLa cells were
transiently transfected with plasmid encoding either LPA1 (A) or 2AR (B) along with -arrestin-2-GFP. The cells were then left untreated, pre-
treated with 5 mM MCD for 1 hour, or treated sequentially with 5 mM MCD for 1 hour and 10 mM water-soluble cholesterol for 1 hour
prior to incubation with 10 M LPA for 2 minutes. The cells were then fixed and processed for indirect immunofluorescence microscopy. The
inset shows a magnified image of the region of the cell indicated by the arrow. (C) The percentage of cells exhibiting recruitment of -arrestin-
2-GFP to punctate plasma membrane spots after 2 minutes agonist stimulation was determined by scoring 100 cells per condition for cells












stimulates PI hydrolysis by associating with Gq in detergent-
resistant membranes. Re-addition of cholesterol to MCD-
treated cells increased both the basal and LPA-stimulated levels
of PI hydrolysis (Fig. 4A). The fact that MCD extraction did
not affect PI hydrolysis by the M1 mAChR suggests that
cholesterol depletion does not impair either Gq or
phospholipase C activity per se, but that LPA1 stimulation of PI
hydrolysis is particularly sensitive to cholesterol depletion (Fig.
4C). Two possible explanations for the difference between LPA1
and M1 mAChRs are that either LPA1 exclusively couples to
Gq that is localized to detergent-resistant membrane domains
or that membrane cholesterol is required for the physical
association of LPA1 with Gq. Second, we found that LPA
stimulation enhanced the resistance of both surface and total
LPA1 to extraction with TX-100 detergent (Fig. 6). Resistance
to detergent extraction is a common property of proteins that
are associated with caveolae and other cholesterol-rich
membrane regions (Razani et al., 2002). The detergent-
resistance of surface LPA1 increased during the first 6 minutes
of LPA treatment and then declined. This is consistent with a
transient association of LPA1 with detergent-resistant
microdomains prior to -arrestin- and clathrin-dependent
endocytosis. Disruption of the actin cytoskeleton with 5 M
cytochalasin D did not alter the agonist-induced detergent
resistance of LPA1 suggesting that the increased detergent
resistance of LPA1 was not due to its association with the actin
cytoskeleton. However, cholesterol extraction completely
prevented the agonist-induced detergent resistance of LPA1,
which is consistent with the notion that LPA1 associates with
cholesterol-rich membrane microdomains.
Interestingly, total detergent-resistant LPA1 staining
increased with time of LPA treatment even after longer periods
of agonist stimulation (Fig. 6B, 30 minutes). We have
previously shown that about 35-40% of surface LPA1 receptors
are internalized into transferrin receptor+ endosomes after 30
minutes of LPA treatment (Murph et al., 2003). We hypothesize
that some of the detergent-resistant LPA1 staining observed
after longer LPA treatment resides in transferrin receptor+
endosomes, which are known to be enriched in cholesterol
(Hao et al., 2002). Finally, a recent study showed that LPA
stimulation of phosphoinositide 3-kinase and the downstream
effector kinase, Akt, was inhibited by MCD treatment in Vero
cells (Peres et al., 2003). Collectively, these data suggest that
LPA1 association with cholesterol-rich plasma membrane
regions is critical for LPA-induced signaling through Gq.
Given that a pool of Gq is present in cholesterol-rich caveolae,
we hypothesize that the localization of LPA1 to detergent-
resistant membranes is important for their association with the
pool of Gq that is localized to these domains.
In support of a role for cholesterol in LPA1 endocytosis, we
found that cholesterol extraction inhibited LPA1 association
with -arrestin and the subsequent clathrin-dependent
endocytosis of the receptor. Many different GPCRs interact
with -arrestins, which is important for the proper regulation
of receptor function (Lefkowitz and Whalen, 2004).
Phosphorylation of specific serine/threonine residues in either
the cytoplasmic tail or the third intracellular loop, by G protein
receptor kinases, leads to the recruitment of -arrestin proteins,
which in turn block G protein/receptor coupling
(desensitization) and also promote clathrin-dependent
endocytosis (Ferguson et al., 1996; Ferguson et al., 1995). Our
data show that wild-type LPA1 receptors transiently recruit -
arrestin-2-GFP to discrete AP2+ structures at the cell surface,
in an agonist-stimulated fashion (Fig. 3), but do not colocalize
on endosomes with -arrestin-2-GFP (Figs 3 and 8). -
arrestins promote clathrin-dependent endocytosis of GPCRs by
localizing receptors to clathrin coated pits through an
interaction of -arrestins with both clathrin heavy chain and
the 2 subunit of the AP-2 clathrin adaptor complex (Goodman
et al., 1996; Laporte et al., 1999). Using MEFs derived from
-arrestin 1 and 2 double-knockout mice, we showed that both
signal attenuation and endocytosis of LPA1 is dependent upon
-arrestin (Figs 2 and 3). Using an RNA interference approach
to reduce the cellular abundance of clathrin heavy chain, we
showed that knockdown of clathrin inhibited the internalization
of LPA1, transferrin receptors, but not the internalization of the
GPI-anchored protein, CD59, which localize to cholesterol-
rich membrane regions (Fig. 1). Taken together, these data
indicate that LPA1 receptors are internalized by -arrestin- and
clathrin-dependent endocytosis.
The most significant finding of these studies was that
cholesterol extraction inhibited -arrestin recruitment to the
plasma membrane by LPA1 and the subsequent endocytosis of
these receptors (Figs 5 and 8) and that re-addition of cholesterol
to MCD treated cells restored both of these functions. As -
arrestin binding to LPA1 precedes receptor endocytosis, we
hypothesize that cholesterol is required for the association of
LPA1 with -arrestins and that it is the lack of -arrestin binding
that leads to the inhibition of LPA1 endocytosis. This is a novel
and previously unappreciated role for membrane cholesterol in
the recruitment of -arrestins. We speculate that other GPCRs
that localize to caveolae may also associate with -arrestin in a
cholesterol-dependent manner. 2ARs localize to caveolae in
cardiomyocytes in the absence of agonist but move out of
caveolae and into clathrin-coated pits upon ligand binding
(Ostrom et al., 2001; Rybin et al., 2000). As 2AR endocytosis
requires -arrestin binding, it is probable that -arrestin also
binds to these receptors in caveolae. Whether the association of
-arrestin with 2ARs in cardiomyocytes is cholesterol-
dependent remains to be determined.
In contrast to LPA1, cholesterol extraction did not inhibit the
endocytosis of M1 mAChRs (Fig. 5), which also follow a -
arrestin- and clathrin-dependent pathway (Vogler et al., 1999)
nor did cholesterol extraction inhibit the association of 2ARs
with -arrestins. This suggests that the cholesterol dependence
of -arrestin recruitment is a unique property of LPA1.
Cholesterol may be important either for the direct recruitment
and binding of -arrestins to LPA1Rs or for the recruitment of
kinases such as GRKs that phosphorylate agonist-stimulated
LPA1. Indeed, GRK4 and GRK6 are palmitoylated, which is
required for their membrane association (Premont et al., 1996;
Stoffel et al., 1994), and palmitoylation has been shown to
target many proteins to cholesterol-rich membranes including
SNARES (Salaun et al., 2005), flotillins (Neumann-Giesen et
al., 2004) and RGS16 (Hiol et al., 2003). Recent work has
shown that both LPA stimulation and activation of protein
kinase C with phorbol esters promotes LPA1 phosphorylation
(Avendano-Vazquez et al., 2005).
Are there physiological contexts where changes in cellular
cholesterol modulate LPA signaling? One intriguing example
may be prostate cancer cells, whose growth is potently
stimulated by LPA. Cholesterol is elevated in these cells and
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contributes to their enhanced growth (Heemers et al., 2001;
Mills and Moolenaar, 2003; Zhuang et al., 2002), perhaps by
augmenting LPA signaling. Future studies should provide the
answer to this and other questions about this novel process.
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